Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1945001rdf:typepubmed:Citationlld:pubmed
pubmed-article:1945001lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:1945001lifeskim:mentionsumls-concept:C0684249lld:lifeskim
pubmed-article:1945001lifeskim:mentionsumls-concept:C0445204lld:lifeskim
pubmed-article:1945001pubmed:issue9lld:pubmed
pubmed-article:1945001pubmed:dateCreated1991-12-23lld:pubmed
pubmed-article:1945001pubmed:abstractTextPreoperative integrated neo-adjuvant radio-chemotherapy was performed in 8 patients suffering from NSCLC bronchial carcinoma at stages IIIA-IIIB (N3 mediastinal). After treatment, 7 patients underwent apparently radical pulmonary exeresis, whereas the patient with adenocarcinoma (T2 N2 M0) was not operated due to the recurrence of disease following supraclavicular lymph node metastasis. Preoperative radio-chemotherapy allows the sub-staging of the disease and the insertion of these patients into the operating programme.lld:pubmed
pubmed-article:1945001pubmed:languageitalld:pubmed
pubmed-article:1945001pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1945001pubmed:citationSubsetIMlld:pubmed
pubmed-article:1945001pubmed:statusMEDLINElld:pubmed
pubmed-article:1945001pubmed:monthSeplld:pubmed
pubmed-article:1945001pubmed:issn0026-4806lld:pubmed
pubmed-article:1945001pubmed:authorpubmed-author:Boidi...lld:pubmed
pubmed-article:1945001pubmed:authorpubmed-author:OliaroAAlld:pubmed
pubmed-article:1945001pubmed:authorpubmed-author:GiobbeRRlld:pubmed
pubmed-article:1945001pubmed:authorpubmed-author:CasadioCClld:pubmed
pubmed-article:1945001pubmed:authorpubmed-author:BrettiSSlld:pubmed
pubmed-article:1945001pubmed:authorpubmed-author:GabrieleA MAMlld:pubmed
pubmed-article:1945001pubmed:authorpubmed-author:BertettoOOlld:pubmed
pubmed-article:1945001pubmed:authorpubmed-author:ClericoMMlld:pubmed
pubmed-article:1945001pubmed:authorpubmed-author:SeroniV TVTlld:pubmed
pubmed-article:1945001pubmed:issnTypePrintlld:pubmed
pubmed-article:1945001pubmed:volume82lld:pubmed
pubmed-article:1945001pubmed:ownerNLMlld:pubmed
pubmed-article:1945001pubmed:authorsCompleteYlld:pubmed
pubmed-article:1945001pubmed:pagination539-43lld:pubmed
pubmed-article:1945001pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:1945001pubmed:meshHeadingpubmed-meshheading:1945001-...lld:pubmed
pubmed-article:1945001pubmed:meshHeadingpubmed-meshheading:1945001-...lld:pubmed
pubmed-article:1945001pubmed:meshHeadingpubmed-meshheading:1945001-...lld:pubmed
pubmed-article:1945001pubmed:meshHeadingpubmed-meshheading:1945001-...lld:pubmed
pubmed-article:1945001pubmed:meshHeadingpubmed-meshheading:1945001-...lld:pubmed
pubmed-article:1945001pubmed:meshHeadingpubmed-meshheading:1945001-...lld:pubmed
pubmed-article:1945001pubmed:meshHeadingpubmed-meshheading:1945001-...lld:pubmed
pubmed-article:1945001pubmed:meshHeadingpubmed-meshheading:1945001-...lld:pubmed
pubmed-article:1945001pubmed:year1991lld:pubmed
pubmed-article:1945001pubmed:articleTitle[Treatment of N2-3 pulmonary carcinoma. Preoperative radio-chemotherapy].lld:pubmed
pubmed-article:1945001pubmed:affiliationReparto di Oncologia Medica, Università di Torino.lld:pubmed
pubmed-article:1945001pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1945001pubmed:publicationTypeEnglish Abstractlld:pubmed